Lifeboat Foundation

What would happen if we created something far smarter than humans?

Age 45: Boring Co ($113M) Age 45: Neuralink ($27M) Age 44: OpenAI (nonprofit) Age 32: Tesla ($59B) Age 30: SpaceX ($30B) Age 28: PayPal ($1.5B) Age 24: Zip2 ($307M)

Pc: unknown.

Our deepfake problem is about to get worse: Samsung engineers have now developed realistic talking heads that can be generated from a single image, so AI can even put words in the mouth of the Mona Lisa.

The new algorithms, developed by a team from the Samsung AI Center and the Skolkovo Institute of Science and Technology, both in Moscow work best with a variety of sample images taken at different angles – but they can be quite effective with just one picture to work from, even a painting.

(Egor Zakharov)

And two of the 60 have intentionally been de-orbited.

Think of it as Material Design for data visualization.

[Image: courtesy Google].

Regulator says certain types of pet food are more frequently connected to heart disease in dogs, but why is unclear.

This week: 🚁 A new mission to Saturn’s largest Moon Titan 🚀 Launching new missions & landing astronauts…on the same night!

🎛️ Restoring the glory to the Apollo Mission Control Room.

There are a few of the stories to tell you about on the latest episode of This Week at NASA! Watch:

A new mouse study highlights the proteins responsible for LC3-associated endocytosis (LANDO), an autophagy process that is involved in degrading β-amyloid, the principal substance associated with Alzheimer’s disease.

Proteostasis

Proteins in the human brain can form misfolded, non-functional, and toxic clumps known as aggregates. Preventing these aggregates from forming, and removing them when they do, is a natural function of the human body, and it is known as proteostasis. However, as we age, this function degrades, and loss of proteostasis is one of the hallmarks of aging. The resulting accumulation of aggregates leads to several deadly diseases, one of which is Alzheimer’s.

Meet National Scientis Dr. Lourdes J. Cruz, a biochemist whose research on Conus geographus venom made a significant impact on neurological medicine.